Bronchitol Mannitol: Phase III started

Pharmaxis began a double-blind, placebo-controlled, international Phase III trial to evaluate 400 mg inhaled Bronchitol twice daily for 26 weeks in 350-440 adult patients. Bronchitol is approved in th...